iPhone | iPad
Android
Huawei
Groundbreaking project to provide comprehensive mapping of mining resources aims to secure investments and stimulate economic growth across Africa
KT APPDOWNLOAD
Neuraxpharm expands operations into the Middle East
Brings leading CNS products, including a product for the treatment of relapsing multiple sclerosis, to new territories
Neuraxpharm Group (Neuraxpharm), a leading European specialty pharmaceutical company focused on the treatment of central nervous system (CNS) disorders, announces the launch of Neuraxpharm Middle East to cover the six members of the Gulf Cooperation Council (GCC) – UAE, the Kingdom of Saudi Arabia, Bahrain, Kuwait, Oman and Qatar – as the Company continues its international expansion.
Neuraxpharm’s move into the Middle East follows the opening of affiliates in Brazil and Mexico in 2023 and adds to the growing list of more than 20 European countries where the Company is now established alongside its global network of distributors.
Neuraxpharm Middle East will be based in Dubai, and will serve as a hub from which to distribute and market a prescription brand indicated for the treatment of adult patients with relapsing multiple sclerosis (RMS), as well as other leading CNS treatments. This pharmaceutical product has been submitted for approval in UAE and the Kingdom of Saudi Arabia with plans for launch in 2025.
This expansion is the next step in Neuraxpharm’s plans to make this and other products available to patients in the Middle East over the coming years.
Dr Jörg-Thomas Dierks, CEO of Neuraxpharm
Commenting on the news, Dr Jörg-Thomas Dierks, CEO of Neuraxpharm, said: "A key pillar of Neuraxpharm’s growth strategy is to establish our own operations in high growth markets and we will continue building our position as a CNS specialist offering differentiated products to local patients and healthcare professionals."
Mental and neurological disorders affect a significant and growing number of people, with one in four people around the world predicted to be affected at some point in their lives. Within this group, there are 2.9 million people around the world living with Multiple Sclerosis (MS), and MS prevalence in the GCC countries ranges from 16 to 105 cases per 100,000 population.
For more information, please visit www.neuraxpharm.com/
More news from KT Network
As a key player in advancing Dubai’s Clean Energy Strategy 2050, Ducab Group powers critical projects that are propelling the city towards becoming a global leader in clean energy and green economy initiatives
Over 50 designers from around the world are set to present their collections across various categories
Aeon & Trisl proudly celebrates a remarkable back-to-back victory, breaking records in the Dubai real estate market
The Center for Leadership Studies and the Situational Leadership Model significantly benefit companies by improving employee engagement and productivity
This campaign offers customers the chance to win incredible prizes, including a dream home, a brand new Jetour T2 SUV, and weekly holiday packages
The course focused on cutting-edge techniques in breast augmentation and lifting, utilising innovative B-Lite implants by Polytech